|

TTRNA-xALT Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Pipeline

Phase 1: 2

Top Sponsors

  • University of Florida2

Indications

  • Cancer2
  • Recurrent Group 4 (Non-SHH/Non-WNT) Medulloblastoma1
  • Recurrent Group 3 Medulloblastoma1
  • Progressive Oligodendroglioma1
  • Recurrent Oligodendroglioma1

Gainesville, Florida2 trials

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

University of Florida Health Shands Hospital

Phase 1
Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

University of Florida Health

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.